Belharra Therapeutics Stock

Belharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.

Sign up today and learn more about Belharra Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Belharra Therapeutics Stock

Belharra Therapeutics is a privately held drug discovery company that is disrupting the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform. Belharra scientists can identify small molecule drug candidates for any binding site, on any protein, in any conformational state, and in any cell type using its chemoproteomics platform. Belharra is based in the San Francisco Bay Area, with its primary lab and offices in San Diego.

Funding History

January 2023$50.0M

Management

CEO

Jeff Jonker

Board Member

Tom Woiwode

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo